Evaluation of cardiac STATus CK-MB/myoglobin device for rapidly ruling out acute myocardial infarction.
The Cardiac STATus CK-MB/Myoglobin device is highly sensitive and has a high negative predictive value within 3 hours of patient presentation. The device may play a role in the re-triage of patients from the CCU to less intensive settings, resulting in a net cost savings.
Brogan
G X
GX
Department of Emergency Medicine, University Medical Center, Stony Brook, New York, USA.
Bock
J L
JL
McCuskey
C F
CF
Hollander
J E
JE
Thode
H
H
Gawad
Y
Y
Jackowski
G
G
D000368:Aged; D002845:Chromatography; D004796:Clinical Enzyme Tests; D003402:Creatine Kinase / Q000097:blood*; D003937:Diagnosis, Differential; D004562:Electrocardiography; D005069:Evaluation Studies as Topic; D005189:False Positive Reactions; D006801:Humans; D007118:Immunoassay / Q000295:instrumentation*; D007527:Isoenzymes; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis*; D009211:Myoglobin / Q000097:blood*; D019095:Point-of-Care Systems; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D013997:Time Factors
D007527:Isoenzymes; D009211:Myoglobin; D003402:Creatine Kinase